ALEXANDRIA, Va., March 12 -- United States Patent no. 12,247,077, issued on March 11, was assigned to Janssen Biotech Inc. (Horsham, Pa.).

"Bispecific EGFR/c-Met antibodies" was invented by Mark Chiu (Paoli, Pa.), Sheri Moores (Phoenixville, Pa.), Joost Neijssen (Ultrecht, Netherlands), Paul Parren (Ultrecht, Netherlands) and Janine Schuurman (Ultrecht, Netherlands).

According to the abstract* released by the U.S. Patent & Trademark Office: "Bispecific EGFR/c-Met antibodies and methods of making and using the molecules."

The patent was filed on Aug. 10, 2021, under Application No. 17/398,294.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1...